Is neoadjuvant chemotherapy the optimal treatment for primary resectable pancreatic cancer?

被引：0
|
作者：
Wang, Yu-song [1 ]
机构：
[1] Second Mil Med Univ, Sch Basic Med Sci, Shanghai 200438, Peoples R China
来源：
HPB | 2020年 / 22卷 / 05期
关键词：
D O I：
10.1016/j.hpb.2020.02.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：790 / 790
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant Treatment in Resectable Pancreatic Cancer. Is It Time for Pushing on It?
    Vivarelli, Marco
    Mocchegiani, Federico
    Nicolini, Daniele
    Vecchi, Andrea
    Conte, Grazia
    Dalla Bona, Enrico
    Rossi, Roberta
    Benedetti Cacciaguerra, Andrea
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer
    Seufferlein, Thomas
    Michalski, Christoph
    CHIRURG, 2022, 93 (05): : 441 - 445
  • [33] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [34] Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer
    Kumar, Rachit
    Jabbour, Salma K.
    JOURNAL OF RADIATION ONCOLOGY, 2013, 2 (04) : 353 - 367
  • [35] Neoadjuvant treatment for resectable pancreatic adenocarcinoma
    Wong, John
    Solomon, Naveenraj L.
    Hsueh, Chung-Tsen
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (01): : 1 - 8
  • [36] Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer
    Lee, Sang Hoon
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 84 (03): : 103 - 110
  • [37] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [38] Neoadjuvant therapy for resectable pancreatic cancer
    Sheikh Hasibur Rahman
    Robin Urquhart
    Michele Molinari
    World Journal of Gastrointestinal Oncology, 2017, (12) : 457 - 465
  • [39] Impact of Neoadjuvant Chemotherapy With Gemcitabine Plus Nab-paclitaxel on the Treatment for Borderline Resectable Pancreatic Cancer
    Miyasaka, Y.
    Ohtsuka, T.
    Kimura, R.
    Mori, Y.
    Nakata, K.
    Nakamura, M.
    PANCREAS, 2019, 48 (10) : 1492 - 1492
  • [40] Neoadjuvant therapy for resectable pancreatic cancer
    Rahman, Sheikh Hasibur
    Urquhart, Robin
    Molinari, Michele
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (12) : 457 - 465
12345